Tenaya Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.79 Insider Own0.30% Shs Outstand66.87M Perf Week-4.11%
Market Cap178.65M Forward P/E- EPS next Y-2.49 Insider Trans- Shs Float63.48M Perf Month-7.89%
Income-123.70M PEG- EPS next Q-0.57 Inst Own55.70% Short Float / Ratio1.42% / 2.45 Perf Quarter45.92%
Sales- P/S- EPS this Y32.70% Inst Trans-6.62% Short Interest0.90M Perf Half Y-15.03%
Book/sh4.40 P/B0.60 EPS next Y8.80% ROA-47.40% Target Price21.50 Perf Year-76.85%
Cash/sh2.76 P/C0.96 EPS next 5Y- ROE-54.20% 52W Range1.64 - 14.43 Perf YTD33.58%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-81.39% Beta-
Dividend %- Quick Ratio8.00 Sales past 5Y- Gross Margin- 52W Low63.72% ATR0.26
Employees141 Current Ratio8.00 Sales Q/Q- Oper. Margin- RSI (14)47.15 Volatility7.23% 9.93%
OptionableYes Debt/Eq0.00 EPS Q/Q3.90% Profit Margin- Rel Volume0.21 Prev Close2.64
ShortableYes LT Debt/Eq0.00 EarningsMar 08 AMC Payout- Avg Volume366.75K Price2.68
Recom1.90 SMA20-6.58% SMA50-8.60% SMA200-23.26% Volume52,192 Change1.70%
Jun-15-22Initiated H.C. Wainwright Buy $25
Mar-08-23 04:01PM
Feb-07-23 05:17PM
Jan-26-23 12:00PM
Jan-09-23 07:00AM
Dec-21-22 06:12AM
04:30PM Loading…
Dec-07-22 04:30PM
Dec-02-22 06:36PM
Nov-28-22 08:30AM
Nov-24-22 05:54AM
Nov-23-22 09:00AM
Nov-21-22 05:45PM
Nov-17-22 12:39AM
Nov-16-22 04:01PM
Nov-10-22 04:05PM
Nov-04-22 08:00AM
06:12AM Loading…
Oct-14-22 06:12AM
Oct-04-22 08:30AM
Sep-29-22 08:00AM
Sep-26-22 09:21AM
Sep-15-22 09:39AM
Sep-06-22 04:05PM
Aug-16-22 09:55AM
Aug-10-22 04:01PM
Jul-06-22 02:00PM
Jun-16-22 08:00AM
May-20-22 08:30AM
May-11-22 04:09PM
May-07-22 09:38AM
08:00AM Loading…
May-03-22 08:00AM
Apr-28-22 08:00AM
Mar-24-22 08:30AM
Mar-23-22 04:05PM
Feb-08-22 12:01PM
Feb-04-22 01:03PM
Jan-31-22 08:00AM
Jan-10-22 08:00AM
Dec-23-21 12:38PM
Dec-22-21 04:05PM
Dec-17-21 10:06AM
Nov-22-21 08:00AM
Nov-19-21 08:00AM
Nov-10-21 04:05PM
Nov-05-21 08:36PM
Nov-03-21 03:41PM
Oct-12-21 06:05PM
Oct-08-21 12:42PM
Oct-04-21 10:54AM
Sep-30-21 06:02PM
Sep-08-21 04:00PM
Aug-31-21 08:00AM
Aug-03-21 04:05PM
Jul-30-21 05:28PM
Jul-29-21 11:46PM
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor of histone deacetylase 6 (HDAC6i) for use in heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM). It is also developing TN-401, an AAV-based gene therapy that addresses genetic arrhythmogenic right ventricular cardiomyopathy (gARVC) caused by plakophilin 2 (PKP2) gene mutations; an AAV-based gene therapy designed to deliver the dwarf open reading frame (DWORF) gene in the heart for DCM; and Reprogramming program, an AAV-based approach for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLUMN GROUP III GP, LP10% OwnerMar 10Buy2.606,77917,59611,377,053Mar 14 04:12 PM
GOEDDEL DAVID VDirectorMar 10Buy2.606,77917,59611,377,053Mar 14 04:09 PM
COLUMN GROUP III GP, LP10% OwnerFeb 08Buy2.601,500,0003,900,00011,370,274Feb 10 04:32 PM
GOEDDEL DAVID VDirectorFeb 08Buy2.601,500,0003,900,00011,370,274Feb 10 04:22 PM
COLUMN GROUP III GP, LP10% OwnerJan 19Buy2.5069,739174,2019,870,274Jan 23 04:25 PM
GOEDDEL DAVID VDirectorJan 19Buy2.5069,739174,2019,870,274Jan 23 04:21 PM
GOEDDEL DAVID VDirectorJan 18Buy2.52135,688341,4329,800,535Jan 19 04:13 PM
COLUMN GROUP III GP, LP10% OwnerJan 18Buy2.52135,688341,4329,800,535Jan 19 04:18 PM
COLUMN GROUP III GP, LP10% OwnerJan 17Buy2.4949,463123,3959,664,847Jan 19 04:18 PM
GOEDDEL DAVID VDirectorJan 17Buy2.4949,463123,3959,664,847Jan 19 04:13 PM
COLUMN GROUP III GP, LP10% OwnerNov 21Buy2.609,615,38424,999,9989,615,384Nov 23 04:12 PM
GOEDDEL DAVID VDirectorNov 21Buy2.609,615,38424,999,9989,615,384Nov 23 04:11 PM
Srivastava DeepakDirectorNov 21Buy2.60230,769599,999372,435Dec 09 07:59 PM
Casdin EliDirectorNov 17Buy2.602,492,0426,479,3096,078,860Nov 25 07:05 PM
Hoey TimothyChief Scientific OfficerApr 26Sale10.131,35313,706198,646Apr 28 07:57 PM